Cigna Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-877
| Closed | -$249K | – | 483 |
|
|
2022
Q1 | $249K | Sell |
877
-269
| -23% | -$76.4K | 0.03% | 502 |
|
|
2021
Q4 | $431K | Sell |
1,146
-503
| -31% | -$189K | 0.03% | 411 |
|
|
2021
Q3 | $681K | Hold |
1,649
| – | – | 0.05% | 335 |
|
|
2021
Q2 | $611K | Sell |
1,649
-300
| -15% | -$111K | 0.04% | 377 |
|
|
2021
Q1 | $565K | Buy |
1,949
+158
| +9% | +$45.8K | 0.04% | 411 |
|
|
2020
Q4 | $447K | Buy |
1,791
+175
| +11% | +$43.7K | 0.03% | 442 |
|
|
2020
Q3 | $366K | Hold |
1,616
| – | – | 0.04% | 432 |
|
|
2020
Q2 | $282K | Buy |
+1,616
| New | +$282K | 0.03% | 564 |
|
|
2019
Q2 | – | Sell |
-1,384
| Closed | -$201K | – | 671 |
|
|
2019
Q1 | $201K | Buy |
+1,384
| New | +$201K | 0.02% | 645 |
|
|
2017
Q4 | – | Sell |
-1,903
| Closed | -$206K | – | 899 |
|
|
2017
Q3 | $206K | Buy |
+1,903
| New | +$206K | 0.01% | 830 |
|